HNO International (HNOI) Research & Development (2022 - 2024)

HNO International has disclosed Research & Development across 3 years of filings, most recently posting $5901.0 for Q1 2024.

• Quarterly Research & Development rose 6384.62% year-over-year to $5901.0 in Q1 2024, while the trailing twelve-month figure through Jan 2024 was $45132.0 (changed N/A YoY) and the FY2023 annual result came in at $43049.0, down 18.65% from the prior year.
• Research & Development declined to $5901.0 in Q1 2024, from $24138.0 in the prior quarter.
• Over five years, Research & Development peaked at $24138.0 in Q4 2023 and troughed at $91.0 in Q1 2023.
• A 3-year average of $10865.3 and a median of $10451.5 in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development retreated 12.41% — and 2024, when it surged 6384.62%.
• Tracing HNOI's Research & Development over 3 years: stood at $2933.0 in 2022, then surged by 722.98% to $24138.0 in 2023, then plunged by 75.55% to $5901.0 in 2024.
• Business Quant data shows HNOI's Research & Development at $5901.0 in Q1 2024, $24138.0 in Q4 2023, and $15002.0 in Q3 2023.